脂肪性-话题@MedSci

#脂肪性#

235篇内容 | 4209人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1810140, encodeId=1c8c18101408e, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Am J Clin Nutr：肠道微生物组靶向治疗非酒精性脂肪性肝病, objectType=article, longId=176604, objectId=43501e660458, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43501e660458, replyNumber=0, likeNumber=66, createdTime=2020-03-14, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43501e660458, moduleTitle=Am J Clin Nutr：肠道微生物组靶向治疗非酒精性脂肪性肝病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43501e660458)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810156, encodeId=cc2a181015690, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=J hepatology：Emricasan在治疗非酒精性脂肪性肝炎（NASH）肝硬化合并门脉高压中患者中的疗效, objectType=article, longId=185405, objectId=309b18540526, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=309b18540526, replyNumber=0, likeNumber=69, createdTime=2020-08-24, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=309b18540526, moduleTitle=J hepatology：Emricasan在治疗非酒精性脂肪性肝炎（NASH）肝硬化合并门脉高压中患者中的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=309b18540526)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810154, encodeId=655618101541e, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Lancet：奥贝胆酸治疗非酒精性脂肪性肝炎III期临床获得成功, objectType=article, longId=184494, objectId=2df618449455, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2df618449455, replyNumber=0, likeNumber=71, createdTime=2020-07-06, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2df618449455, moduleTitle=Lancet：奥贝胆酸治疗非酒精性脂肪性肝炎III期临床获得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2df618449455)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810143, encodeId=d10d181014392, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=AP&T：长期使用二甲双胍可改善糖尿病患者的非酒精性脂肪性肝炎和肝硬化的临床预后, objectType=article, longId=177409, objectId=01b81e7409e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01b81e7409e2, replyNumber=0, likeNumber=58, createdTime=2020-01-21, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01b81e7409e2, moduleTitle=AP&T：长期使用二甲双胍可改善糖尿病患者的非酒精性脂肪性肝炎和肝硬化的临床预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01b81e7409e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810133, encodeId=ca5a18101330d, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Gastroenterology：非酒精性脂肪性肝病与肠道微生物群变化, objectType=article, longId=174703, objectId=86bd1e470383, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86bd1e470383, replyNumber=0, likeNumber=77, createdTime=2020-01-01, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86bd1e470383, moduleTitle=Gastroenterology：非酒精性脂肪性肝病与肠道微生物群变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86bd1e470383)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810170, encodeId=199a18101e0aa, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Gastroenterology：belapectin用于治疗非酒精性脂肪性肝炎、肝硬化和门脉高压患者, objectType=article, longId=192704, objectId=676e192e04a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=676e192e04a1, replyNumber=0, likeNumber=74, createdTime=2021-01-01, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=676e192e04a1, moduleTitle=Gastroenterology：belapectin用于治疗非酒精性脂肪性肝炎、肝硬化和门脉高压患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=676e192e04a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810161, encodeId=3ca718101615a, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Lancet Gastroen Hepatol：非侵入性高风险非酒精性脂肪性肝炎患者识别方法, objectType=article, longId=187430, objectId=e81d18e43040, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e81d18e43040, replyNumber=0, likeNumber=67, createdTime=2020-11-18, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e81d18e43040, moduleTitle=Lancet Gastroen Hepatol：非侵入性高风险非酒精性脂肪性肝炎患者识别方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e81d18e43040)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810153, encodeId=f4c8181015363, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=AJG：性别不再是非酒精性脂肪性肝病的女性心血管疾病的保护因素, objectType=article, longId=183884, objectId=019d18388499, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=019d18388499, replyNumber=0, likeNumber=52, createdTime=2020-07-01, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=019d18388499, moduleTitle=AJG：性别不再是非酒精性脂肪性肝病的女性心血管疾病的保护因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=019d18388499)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810168, encodeId=ee3c1810168eb, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=AJG：非酒精性脂肪性肝病和肌肉减少症与心血管风险独立相关 , objectType=article, longId=190557, objectId=e46219055e43, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e46219055e43, replyNumber=0, likeNumber=72, createdTime=2020-11-30, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e46219055e43, moduleTitle=AJG：非酒精性脂肪性肝病和肌肉减少症与心血管风险独立相关 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e46219055e43)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810147, encodeId=ad6e181014ebf, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Clin Gastroenterology H：非酒精性脂肪性肝病患者的健康相关生活质量与肝脏炎症有关, objectType=article, longId=178926, objectId=63151e892650, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63151e892650, replyNumber=0, likeNumber=94, createdTime=2020-01-06, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63151e892650, moduleTitle=Clin Gastroenterology H：非酒精性脂肪性肝病患者的健康相关生活质量与肝脏炎症有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63151e892650)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810141, encodeId=5ca4181014119, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=J INTERN MED：非酒精性脂肪性肝病增加了发生晚期慢性肾病的风险, objectType=article, longId=176936, objectId=2cc91e6936cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cc91e6936cf, replyNumber=0, likeNumber=104, createdTime=2020-06-30, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cc91e6936cf, moduleTitle=J INTERN MED：非酒精性脂肪性肝病增加了发生晚期慢性肾病的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cc91e6936cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810136, encodeId=5969181013621, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Dig Liver Dis：膳食中维生素E和C能减缓非酒精性脂肪性肝病的病情, objectType=article, longId=174997, objectId=34461e499727, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34461e499727, replyNumber=0, likeNumber=0, createdTime=2019-10-12, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34461e499727, moduleTitle=Dig Liver Dis：膳食中维生素E和C能减缓非酒精性脂肪性肝病的病情, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34461e499727)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810160, encodeId=dcbb181016005, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=J Hepatology：微生物群导致的肠道血管屏障破坏是非酒精性脂肪性肝炎发展的前提, objectType=article, longId=186947, objectId=9d2e18694e78, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d2e18694e78, replyNumber=0, likeNumber=72, createdTime=2020-03-24, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d2e18694e78, moduleTitle=J Hepatology：微生物群导致的肠道血管屏障破坏是非酒精性脂肪性肝炎发展的前提, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d2e18694e78)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810146, encodeId=f3811810146de, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=非酒精性脂肪性肝炎（NASH）的治疗：ASC40获得中国NMPA的IND, objectType=article, longId=178354, objectId=2b001e835408, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b001e835408, replyNumber=0, likeNumber=72, createdTime=2019-09-02, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b001e835408, moduleTitle=非酒精性脂肪性肝炎（NASH）的治疗：ASC40获得中国NMPA的IND, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b001e835408)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810139, encodeId=14ad18101392c, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Lancet Gastroen Hepatol：去甲熊去氧胆酸降低非酒精性脂肪性肝病患血清ALT, objectType=article, longId=176067, objectId=050f1e6067e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=050f1e6067e3, replyNumber=0, likeNumber=90, createdTime=2019-08-04, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=050f1e6067e3, moduleTitle=Lancet Gastroen Hepatol：去甲熊去氧胆酸降低非酒精性脂肪性肝病患血清ALT, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=050f1e6067e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810157, encodeId=5f4d181015e1f, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Diabetes Care：2型糖尿病患者非酒精性脂肪性肝炎的经济和临床负担, objectType=article, longId=185881, objectId=6fa118588156, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fa118588156, replyNumber=0, likeNumber=86, createdTime=2020-05-05, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fa118588156, moduleTitle=Diabetes Care：2型糖尿病患者非酒精性脂肪性肝炎的经济和临床负担, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fa118588156)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810127, encodeId=de74181012eb3, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=非酒精性脂肪性肝炎：cilofexor/firsocostat组合在概念验证研究中改善了NASH症状, objectType=article, longId=164168, objectId=8b68164168af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b68164168af, replyNumber=0, likeNumber=64, createdTime=2020-02-10, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b68164168af, moduleTitle=非酒精性脂肪性肝炎：cilofexor/firsocostat组合在概念验证研究中改善了NASH症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b68164168af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810134, encodeId=344518101343b, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Boehringer Ingelheim与韩国Yuhan签订8.7亿美元合同，合作开发非酒精性脂肪性肝炎的双重激动剂, objectType=article, longId=174741, objectId=97ed1e4741da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97ed1e4741da, replyNumber=0, likeNumber=94, createdTime=2019-10-30, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97ed1e4741da, moduleTitle=Boehringer Ingelheim与韩国Yuhan签订8.7亿美元合同，合作开发非酒精性脂肪性肝炎的双重激动剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97ed1e4741da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810148, encodeId=7dbf181014887, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Enanta宣布其FXR激动剂EDP-305治疗非酒精性脂肪性肝炎的临床研究积极成果, objectType=article, longId=180093, objectId=cf0518009397, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf0518009397, replyNumber=0, likeNumber=65, createdTime=2020-03-30, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf0518009397, moduleTitle=Enanta宣布其FXR激动剂EDP-305治疗非酒精性脂肪性肝炎的临床研究积极成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf0518009397)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810164, encodeId=f404181016406, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Intern Med：非酒精性脂肪性肝炎患者自身免疫性胃炎高发, objectType=article, longId=189314, objectId=5e51189314c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e51189314c0, replyNumber=0, likeNumber=53, createdTime=2020-08-29, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e51189314c0, moduleTitle=Intern Med：非酒精性脂肪性肝炎患者自身免疫性胃炎高发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e51189314c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

脂肪性

2020-05-29

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Am J Clin Nutr：肠道微生物组靶向治疗非酒精性脂肪性肝病

2020-03-14

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

J hepatology：Emricasan在治疗非酒精性脂肪性肝炎（NASH）肝硬化合并门脉高压中患者中的疗效

2020-08-24

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Lancet：奥贝胆酸治疗非酒精性脂肪性肝炎III期临床获得成功

2020-07-06

zhouqu_8 (审核中...)

前往app查看评论内容

#脂肪性#

AP&T：长期使用二甲双胍可改善糖尿病患者的非酒精性脂肪性肝炎和肝硬化的临床预后

2020-01-21

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Gastroenterology：非酒精性脂肪性肝病与肠道微生物群变化

2020-01-01

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Gastroenterology：belapectin用于治疗非酒精性脂肪性肝炎、肝硬化和门脉高压患者

2021-01-01

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Lancet Gastroen Hepatol：非侵入性高风险非酒精性脂肪性肝炎患者识别方法

2020-11-18

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

AJG：性别不再是非酒精性脂肪性肝病的女性心血管疾病的保护因素

2020-07-01

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

AJG：非酒精性脂肪性肝病和肌肉减少症与心血管风险独立相关

2020-11-30

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Clin Gastroenterology H：非酒精性脂肪性肝病患者的健康相关生活质量与肝脏炎症有关

2020-01-06

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

J INTERN MED：非酒精性脂肪性肝病增加了发生晚期慢性肾病的风险

2020-06-30

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Dig Liver Dis：膳食中维生素E和C能减缓非酒精性脂肪性肝病的病情

2019-10-12

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

J Hepatology：微生物群导致的肠道血管屏障破坏是非酒精性脂肪性肝炎发展的前提

2020-03-24

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

非酒精性脂肪性肝炎（NASH）的治疗：ASC40获得中国NMPA的IND

2019-09-02

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Lancet Gastroen Hepatol：去甲熊去氧胆酸降低非酒精性脂肪性肝病患血清ALT

2019-08-04

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Diabetes Care：2型糖尿病患者非酒精性脂肪性肝炎的经济和临床负担

2020-05-05

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

非酒精性脂肪性肝炎：cilofexor/firsocostat组合在概念验证研究中改善了NASH症状

2020-02-10

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Boehringer Ingelheim与韩国Yuhan签订8.7亿美元合同，合作开发非酒精性脂肪性肝炎的双重激动剂

2019-10-30

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Enanta宣布其FXR激动剂EDP-305治疗非酒精性脂肪性肝炎的临床研究积极成果

2020-03-30

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Intern Med：非酒精性脂肪性肝炎患者自身免疫性胃炎高发

2020-08-29

科室
- - 订阅+
  - 更多科室
工具
服务